AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wagner, J.
Right arrow Articles by Ignatius, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wagner, J.
Right arrow Articles by Ignatius, R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2003, p. 2358-2361, Vol. 47, No. 7
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.7.2358-2361.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Susceptibilities of Campylobacter jejuni Isolates from Germany to Ciprofloxacin, Moxifloxacin, Erythromycin, Clindamycin, and Tetracycline

Jutta Wagner,1* Miriam Jabbusch,1 Martin Eisenblätter,1 Helmut Hahn,1 Constanze Wendt,2 and Ralf Ignatius1

Department of Medical Microbiology and Immunology of Infection, Institute of Infectious Diseases Medicine, Benjamin Franklin Medical Center, Free University of Berlin, 12203 Berlin,1 Institute of Hygiene, University of Heidelberg, 69129 Heidelberg, Germany2

Received 5 August 2002/ Returned for modification 11 February 2003/ Accepted 17 April 2003

To elucidate Campylobacter jejuni resistance to antibiotics in Germany, MICs of ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline were determined (using agar dilution) for 144 clinical isolates. The data indicate a considerable ciprofloxacin resistance (45.1%) without a clonal relationship of the strains and a greater in vitro activity of moxifloxacin, erythromycin, and clindamycin.


* Corresponding author. Mailing address: Department of Medical Microbiology and Immunology of Infection, Institute of Infectious Diseases Medicine, Benjamin Franklin Medical Center, Free University of Berlin, Hindenburgdamm 27, 12203 Berlin, Germany. Phone: 49 30 8445 3656. Fax: 49 30 8445 3830. E-mail: jutta.wagner{at}medizin.fu-berlin.de.


Antimicrobial Agents and Chemotherapy, July 2003, p. 2358-2361, Vol. 47, No. 7
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.7.2358-2361.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.